ORIC Pharamceuticals (ORIC) PT Lowered to $18 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Price: $9.24 +2.78%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on ORIC Pharamceuticals (NASDAQ: ORIC) to $18.00 (from $19.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Cantor Fitzgerald: 'ORIC Sell-Off on JNJ RIPTAC Data Way Overdone'
- Stryker (SYK) PT Lowered to $325 at Piper Sandler
- Intel (INTC) PT Lowered to $90 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
